Ghent, Belgium, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA (the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in ...
In its October 2024 meeting, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave the green light for Korjuny (catumaxomab, Lindis Biotech GmbH) to be used ...
, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Ghent, Belgium - 14 October 2025 - Sequana Medical NV (Euronext Brussels: SEQUA (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback